☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Transcenta
Transcenta Reports First Patient Dosing in P-I Study of TST002 for the Treatment of Osteoporosis in China
April 28, 2022
PharmaShots Weekly Snapshots (November 09-13, 2020)
November 13, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
